Department of Psychosis Studies, King's College London, Institute of Psychiatry, London, England2OASIS Service, South London and the Maudsley National Health Service Foundation Trust, London, England3Department of Brain and Behavioral Sciences, University.
Department of Psychosis Studies, King's College London, Institute of Psychiatry, London, England3Department of Brain and Behavioral Sciences, University of Pavia, Pavia, Italy.
JAMA Psychiatry. 2016 Mar;73(3):211-20. doi: 10.1001/jamapsychiatry.2015.2313.
The prognostic significance of competing constructs and operationalizations for brief psychotic episodes (acute and transient psychotic disorder [ATPD], brief psychotic disorder [BPD], brief intermittent psychotic symptoms [BIPS], and brief limited intermittent psychotic symptoms [BLIPS]) is unknown.
To provide a meta-analytical prognosis of the risk of psychotic recurrence in patients with remitted first-episode ATPD, BPD, BIPS, and BLIPS and in a benchmark group of patients with remitted first-episode schizophrenia (FES). We hypothesized a differential risk: FES > ATPD > BPD > BIPS > BLIPS.
The Web of Knowledge and Scopus databases were searched up to May 18, 2015; the articles identified were reviewed as well as citations of previous publications and results of a manual search of the reference lists of retrieved articles.
We included original articles that reported the risk of psychotic recurrence at follow-up for patients in remission from first-episode ATPD, BPD, BLIPS, BIPS, and FES.
Independent extraction by multiple observers. Random-effects meta-analysis was performed, and moderators were tested with meta-regression analyses, Bonferroni corrected. Heterogeneity was assessed with the I2 index. Sensitivity analyses tested the robustness of the results. Publication bias was assessed with funnel plots and the Egger test.
Proportion of patients with baseline ATPD, BPD, BLIPS, and BIPS who had any psychotic recurrence at 6, 12, 24, and 36 or more months of follow-up.
Eighty-two independent studies comprising up to 11,133 patients were included. There was no prognostic difference in risk of psychotic recurrence between ATPD, BPD, BLIPS, and BIPS at any follow-up (P > .03). In the long-term analysis, risk of psychotic recurrence (reported as mean [95% CI]) was significantly higher in the FES group (0.78 [0.58-0.93] at 24 months and 0.84 [0.70-0.94] at ≥ 36 months; P < .02 and P < .001, respectively) compared with the other 4 groups (0.39 [0.32-0.47] at 24 months and 0.51 [0.41-0.61] at ≥ 36 months). There were no publication biases. Sex and exposure to antipsychotic medication modulated the meta-analytical estimates (.002 < P < .03).
There are no prognostic differences in risk of psychotic recurrence between ATPD, BPD, BLIPS, and BIPS constructs of brief psychotic episodes. Conversely, there is consistent meta-analytical evidence for better long-term prognosis of brief psychotic episodes compared with remitted first-episode schizophrenia. These findings should influence the diagnostic practice and clinical services in the management of early psychosis.
短暂精神病发作(急性和短暂精神病障碍[ATPD]、短暂精神病障碍[BPD]、短暂间歇性精神病症状[BIPS]和短暂有限间歇性精神病症状[BLIPS])的竞争结构和操作的预后意义尚不清楚。
提供缓解首发 ATPD、BPD、BIPS 和 BLIPS 患者以及缓解首发精神分裂症(FES)患者基准组中精神病复发风险的荟萃分析。我们假设存在差异风险:FES>ATPD>BPD>BIPS>BLIPS。
Web of Knowledge 和 Scopus 数据库检索至 2015 年 5 月 18 日;还对已确定的文章进行了审查,并查阅了以前出版物的参考文献和检索文章的参考文献列表的结果。
我们纳入了报告缓解期首发 ATPD、BPD、BLIPS、BIPS 和 FES 患者随访期间精神病复发风险的原始文章。
由多个观察者进行独立提取。进行了随机效应荟萃分析,并使用荟萃回归分析对调节剂进行了测试,采用 Bonferroni 校正。使用 I2 指数评估异质性。敏感性分析测试了结果的稳健性。使用漏斗图和 Egger 检验评估发表偏倚。
在 6、12、24 和 36 个月或更长时间的随访中,基线 ATPD、BPD、BLIPS 和 BIPS 患者中任何精神病复发的患者比例。
共纳入 82 项独立研究,共纳入 11133 名患者。在任何随访中,ATPD、BPD、BLIPS 和 BIPS 之间精神病复发的风险均无差异(P>0.03)。在长期分析中,FES 组精神病复发的风险(报告为平均值[95%CI])明显更高(24 个月时为 0.78[0.58-0.93],≥36 个月时为 0.84[0.70-0.94];P<0.02 和 P<0.001)与其他 4 组相比(24 个月时为 0.39[0.32-0.47],≥36 个月时为 0.51[0.41-0.61])。没有发表偏倚。性别和抗精神病药物暴露调节了荟萃分析的估计值(0.002<P<0.03)。
在 ATPD、BPD、BLIPS 和 BIPS 短暂精神病发作结构中,精神病复发风险无预后差异。相反,有一致的荟萃分析证据表明,与缓解首发精神分裂症相比,短暂精神病发作有更好的长期预后。这些发现应该影响早期精神病诊断实践和临床服务管理。